Back to all biomarkers
Genetic
Pharmacogenomics Panel
Tests how your genes affect drug metabolism — enabling personalized medication selection and dosing.
Optimal Range
Variants in CYP2D6, CYP2C19, CYP3A4, etc.
Why It Matters
Genetic variants in drug-metabolizing enzymes mean the same medication can be effective, useless, or toxic depending on your genotype. Pharmacogenomic testing prevents adverse drug reactions and optimizes treatment — especially for statins, antidepressants, and blood thinners.